Steven Cohen's position in Theravance Biopharma is currently worth $1.07 Million. That's 0.01% of their equity portfolio (777th largest holding). The first Theravance Biopharma trade was made in Q4 2016. Since then Steven Cohen bought shares two more times and sold shares on four occasions. The investor's estimated purchase price is $1.17 Million, resulting in a loss of 8.1%.
Theravance Biopharma, Inc. (NASDAQ:NASDAQ:TBPH) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Gail Cohen – Corporate Commun...Seeking Alpha, about 2 months ago
Theravance Biopharma, Inc. (NASDAQ:NASDAQ:TBPH) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Gail Cohen – Vice President-Corp...Seeking Alpha, 5 months ago
Billionaire guru invests in biotech company Check out Steven Cohen Stock Picks » Download GuruFolio Report of Steven Cohen (Updated on 09/07/2021) Related St...GuruFocus, about 1 year ago